Package 31722-705-01

{"route": ["ORAL"], "spl_id": "461ff6f2-7bf1-82fb-e063-6294a90acb06", "openfda": {"upc": ["0331722704304", "0331722705301"], "unii": ["G447S0T1VC"], "rxcui": ["313564", "313565"], "spl_set_id": ["7f5e96e0-534c-47a5-bb79-926088afc73c"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (31722-705-01)", "package_ndc": "31722-705-01", "marketing_start_date": "20150525"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (31722-705-05)", "package_ndc": "31722-705-05", "marketing_start_date": "20150525"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (31722-705-30)", "package_ndc": "31722-705-30", "marketing_start_date": "20150525"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (31722-705-60)", "package_ndc": "31722-705-60", "marketing_start_date": "20150525"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (31722-705-90)", "package_ndc": "31722-705-90", "marketing_start_date": "20150525"}], "brand_name": "Valacyclovir", "product_id": "31722-705_461ff6f2-7bf1-82fb-e063-6294a90acb06", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "31722-705", "generic_name": "Valacyclovir", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "1 g/1"}], "application_number": "ANDA203047", "marketing_category": "ANDA", "marketing_start_date": "20150525", "listing_expiration_date": "20261231"}